ABIN953573

antibody from antibodies-online

Targeting: MYL9 LC20, MLC2, MRLC1, MYRL2

Provider product page for ABIN953573

Western blot

Antibody data

Antibody Data
Antigen structure
References [5]
Comments [0]
Validations
Western blot [1]

Submit

Product number: ABIN953573 - Provider product page
Provider: antibodies-online
Product name: anti-Myosin Regulatory Light Chain 2, Smooth Muscle Isoform (MYL9) (AA 95-125), (C-Term) antibody
Antibody type: Polyclonal
Description: Purified through a Protein A column followed by peptide affinity purification
Reactivity: Human
Host: Rabbit
Epitope: C-Term, AA 95-125
Vial size: 0.4 mL
Storage: Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Handling: Avoid repeated freezing and thawing.

MYL9 protein structure - ABIN953573 shown in red.

Submitted references MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.

Gilles L, Bluteau D, Boukour S, Chang Y, Zhang Y, Robert T, Dessen P, Debili N, Bernard OA, Vainchenker W, Raslova H
Blood 2009 Nov 5;114(19):4221-32

Smooth muscle type isoform of 20 kDa myosin light chain is expressed in monocyte/macrophage cell lineage.

Higashihara M, Watanabe M, Usuda S, Miyazaki K
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 2008 Feb;44(1):29-40

The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.

Szczesna-Cordary D, Guzman G, Zhao J, Hernandez O, Wei J, Diaz-Perez Z
Journal of cell science 2005 Aug 15;118(Pt 16):3675-83

Smooth muscle contraction and relaxation.

Webb RC
Advances in physiology education 2003 Dec;27(1-4):201-6

The DNA sequence and comparative analysis of human chromosome 20.

Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J
Nature 2001 Dec 20-27;414(6866):865-71